NCT00250601View on ClinicalTrials.gov

An Eight-week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With Depression

PHASE3CompletedINTERVENTIONAL
Enrollment

460

Participants

Timeline

Start Date

April 30, 2005

Primary Completion Date

July 31, 2007

Study Completion Date

July 31, 2007

Conditions
Depressive Disorder
Interventions
DRUG

Saredutant succinate (SR48968C)

Trial Locations (1)

08807

Administrative Office, Bridgewater

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY